Jen-Chih Tseng
Overview
Explore the profile of Jen-Chih Tseng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
327
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin T, Chen P, Lin C, Wang B, Kuo Y, Yeh C, et al.
BMC Cancer
. 2025 Jan;
25(1):95.
PMID: 39819475
Background: Caffeic acid phenethyl ester (CAPE) is the main bioactive component of poplar type propolis. We previously reported that treatment with caffeic acid phenethyl ester (CAPE) suppressed the cell proliferation,...
2.
Imana Z, Tseng J, Yang J, Liu Y, Lin P, Huang M, et al.
Biomed Pharmacother
. 2024 Nov;
181:117692.
PMID: 39561589
Head and neck cancer ranks as the sixth most common cancer worldwide, highlighting the critical need for the development of new therapies to enhance treatment efficacy. The activation of innate...
3.
Yang J, Chuang Y, Tseng J, Liu Y, Lai C, Lee A, et al.
J Exp Clin Cancer Res
. 2024 Jun;
43(1):169.
PMID: 38880883
Background: Cancer is characterized by dysregulated cellular metabolism. Thus, understanding the mechanisms underlying these metabolic alterations is important for developing targeted therapies. In this study, we investigated the pro-tumoral effect...
4.
Yang J, Tseng J, Tien C, Lee C, Liu Y, Lin J, et al.
Int J Biol Sci
. 2023 Jun;
19(9):2897-2913.
PMID: 37324951
Vaccines are a powerful medical intervention for preventing epidemic diseases. Efficient inactivated or protein vaccines typically rely on an effective adjuvant to elicit an immune response and boost vaccine activity....
5.
Tseng J, Yang J, Lee C, Lo C, Liu Y, Zhang M, et al.
Int J Biol Sci
. 2023 Jun;
19(9):2648-2662.
PMID: 37324949
Head and neck cancer is a major cancer type, with high motility rates that reduce the quality of life of patients. Herein, we investigated the effectiveness and mechanism of a...
6.
Tseng J, Wang B, Wang Y, Kuo Y, Chen J, Hour T, et al.
Phytomedicine
. 2023 May;
116:154860.
PMID: 37201366
Background: Epidermal growth factor receptor (EGFR) is upregulated in prostate cancer (PCa). However, suppression of EGFR did not improve the patient outcome, possibly due to the activation of PI3K/Akt signaling...
7.
Lin C, Wang B, Fu Y, Huo C, Wang Y, Chen B, et al.
Clin Transl Med
. 2022 Mar;
12(3):e764.
PMID: 35343073
No abstract available.
8.
Yang J, Tseng J, Yu G, Luo Y, Huang C, Hong Y, et al.
Pharmaceutics
. 2022 Feb;
14(2).
PMID: 35214155
Vaccines are powerful tools for controlling microbial infections and preventing epidemic diseases. Efficient inactive, subunit, or viral-like particle vaccines usually rely on a safe and potent adjuvant to boost the...
9.
Fu Y, Wang B, Tseng J, Huang S, Lin C, Kuo Y, et al.
J Biomed Sci
. 2022 Feb;
29(1):16.
PMID: 35197069
Background: Docetaxel has been approved by USFDA as a first-line treatment for castration-resistant prostate cancer (CRPC) patients. Patients receiving androgen deprivation therapy along with docetaxel result in superior survival, lower...
10.
Tseng J, Yang J, Liu Y, Su Y, Lee A, Chen Y, et al.
Cancer Immunol Immunother
. 2021 Sep;
71(5):1115-1128.
PMID: 34581869
Head and neck cancers are a type of life-threatening cancers characterized by an immunosuppressive tumor microenvironment. Only less than 20% of the patients respond to immune checkpoint blockade therapy, indicating...